Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration

Gastrodin, a traditional Chinese medicine ingredient, is widely used to treat vascular and neurological diseases. However, recently, an increasing number of studies have shown that gastrodin has anti-osteoporosis effects, and its mechanisms of action include its antioxidant effect, anti-inflammatory...

Full description

Bibliographic Details
Main Authors: Yi Li, Fenglan Li
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/11/1432
_version_ 1827643954114330624
author Yi Li
Fenglan Li
author_facet Yi Li
Fenglan Li
author_sort Yi Li
collection DOAJ
description Gastrodin, a traditional Chinese medicine ingredient, is widely used to treat vascular and neurological diseases. However, recently, an increasing number of studies have shown that gastrodin has anti-osteoporosis effects, and its mechanisms of action include its antioxidant effect, anti-inflammatory effect, and anti-apoptotic effect. In addition, gastrodin has many unique advantages in promoting bone healing in tissue engineering, such as inducing high hydrophilicity in the material surface, its anti-inflammatory effect, and pro-vascular regeneration. Therefore, this paper summarized the effects and mechanisms of gastrodin on osteoporosis and bone regeneration in the current research. Here we propose an assumption that the use of gastrodin in the surface loading of oral implants may greatly promote the osseointegration of implants and increase the success rate of implants. In addition, we speculated on the potential mechanisms of gastrodin against osteoporosis, by affecting actin filament polymerization, renin–angiotensin system (RAS) and ferroptosis, and proposed that the potential combination of gastrodin with Mg<sup>2+</sup>, angiotensin type 2 receptor blockers or artemisinin may greatly inhibit osteoporosis. The purpose of this review is to provide a reference for more in-depth research and application of gastrodin in the treatment of osteoporosis and implant osseointegration in the future.
first_indexed 2024-03-09T18:04:50Z
format Article
id doaj.art-b1cb240a2e65472b8464bd553da520e0
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T18:04:50Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-b1cb240a2e65472b8464bd553da520e02023-11-24T09:35:38ZengMDPI AGPharmaceuticals1424-82472022-11-011511143210.3390/ph15111432Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and OsseointegrationYi Li0Fenglan Li1Department of Prosthodontics, Shanxi Provincial People’s Hospital, Shanxi Medical University, Taiyuan 030000, ChinaDepartment of Prosthodontics, Shanxi Provincial People’s Hospital, Shanxi Medical University, Taiyuan 030000, ChinaGastrodin, a traditional Chinese medicine ingredient, is widely used to treat vascular and neurological diseases. However, recently, an increasing number of studies have shown that gastrodin has anti-osteoporosis effects, and its mechanisms of action include its antioxidant effect, anti-inflammatory effect, and anti-apoptotic effect. In addition, gastrodin has many unique advantages in promoting bone healing in tissue engineering, such as inducing high hydrophilicity in the material surface, its anti-inflammatory effect, and pro-vascular regeneration. Therefore, this paper summarized the effects and mechanisms of gastrodin on osteoporosis and bone regeneration in the current research. Here we propose an assumption that the use of gastrodin in the surface loading of oral implants may greatly promote the osseointegration of implants and increase the success rate of implants. In addition, we speculated on the potential mechanisms of gastrodin against osteoporosis, by affecting actin filament polymerization, renin–angiotensin system (RAS) and ferroptosis, and proposed that the potential combination of gastrodin with Mg<sup>2+</sup>, angiotensin type 2 receptor blockers or artemisinin may greatly inhibit osteoporosis. The purpose of this review is to provide a reference for more in-depth research and application of gastrodin in the treatment of osteoporosis and implant osseointegration in the future.https://www.mdpi.com/1424-8247/15/11/1432gastrodinosteoporosisbone regenerationosseointegrationactin filamentrenin-angiotensin system
spellingShingle Yi Li
Fenglan Li
Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration
Pharmaceuticals
gastrodin
osteoporosis
bone regeneration
osseointegration
actin filament
renin-angiotensin system
title Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration
title_full Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration
title_fullStr Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration
title_full_unstemmed Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration
title_short Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration
title_sort mechanism and prospect of gastrodin in osteoporosis bone regeneration and osseointegration
topic gastrodin
osteoporosis
bone regeneration
osseointegration
actin filament
renin-angiotensin system
url https://www.mdpi.com/1424-8247/15/11/1432
work_keys_str_mv AT yili mechanismandprospectofgastrodininosteoporosisboneregenerationandosseointegration
AT fenglanli mechanismandprospectofgastrodininosteoporosisboneregenerationandosseointegration